Partial Clinical Remission Reduces Lipid-Based Cardiovascular Risk in Adult Patients With Type 1 Diabetes

IMPORTANCE: Risk factors for atherosclerotic cardiovascular disease (ASCVD) are well established in type 2 diabetes (T2D), but not in type 1 diabetes (T1D). The impact of partial clinical remission (PR) on short-term ASCVD risk in T1D is unclear. AIM: To investigate the impact of PR on the earliest...

Descripción completa

Detalles Bibliográficos
Autores principales: Nwosu, Benjamin Udoka, Parajuli, Sadichchha, Khatri, Krish, Jasmin, Gabrielle, Al-Halbouni, Layana, Lee, Austin F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660113/
https://www.ncbi.nlm.nih.gov/pubmed/34899592
http://dx.doi.org/10.3389/fendo.2021.705565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660113/
https://www.ncbi.nlm.nih.gov/pubmed/34899592
http://dx.doi.org/10.3389/fendo.2021.705565

Ejemplares similares